Imagem da capa

Structure dynamics and solvation of HIV-1 protease wildtype complexed with inhibitors by molecular dynamic simulations

Thesis (Ph.D.)--Chulalongkorn University, 2006

Na minha lista:

Detalhes bibliográficos
Autor principal:	Kitiyaporn Wittayanarakul (Author)
Outros Autores:	Supot Hannongbua (Contributor), Pornthep Sompornpisut (Contributor), Michael Feig (Contributor), Chulalongkorn University. Faculty of Science (Contributor)
Formato:	Livro
Publicado em:	Chulalongkorn University, 2014-03-23T06:04:13Z.
Assuntos:	Thesis
Acesso em linha:	Connect to this object online.
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados

Structure and dynamic of HIV-1 Integrase : molecular modeling and molecular dynamics simulations
Por: Atchara Wijitkosoom
Publicado em: (2014)

Structure and dynamic of HIV-1 Integrase : molecular modeling and molecular dynamics simulations
Por: Atchara Wijitkosoom
Publicado em: (2013)

Solvation and Aggregation of Meta-Aminobenzoic Acid in Water: Density Functional Theory and Molecular Dynamics Study
Por: Etienne Gaines, et al.
Publicado em: (2018)

In Silico Prediction of Novel Inhibitors of SARS-CoV-2 Main Protease through Structure-Based Virtual Screening and Molecular Dynamic Simulation
Por: Sobia Ahsan Halim, et al.
Publicado em: (2021)

Design of Potent Inhibitors Targeting the Main Protease of SARS-CoV-2 Using QSAR Modeling, Molecular Docking, and Molecular Dynamics Simulations
Por: Mehdi Oubahmane, et al.
Publicado em: (2023)

Molecular Dynamics Simulation
Publicado em: (2014)

Molecular Dynamics Simulations of Hsp90 with an Eye to Inhibitor Design
Por: Giorgio Colombo, et al.
Publicado em: (2012)

In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing
Por: Yogesh Kumar, et al.
Publicado em: (2020)

Discovery of genistein derivatives as potential SARS-CoV-2 main protease inhibitors by virtual screening, molecular dynamics simulations and ADMET analysis
Por: Jiawei Liu, et al.
Publicado em: (2022)

Discovery of Novel and Highly Potent Inhibitors of SARS CoV-2 Papain-Like Protease Through Structure-Based Pharmacophore Modeling, Virtual Screening, Molecular Docking, Molecular Dynamics Simulations, and Biological Evaluation
Por: Xiaoyan Tian, et al.
Publicado em: (2022)

Molecular Docking and Dynamics Simulations Reveal the Potential of Anti-HCV Drugs to Inhibit COVID-19 Main Protease
Por: Ahmed Ali Al-Karmalawy, et al.
Publicado em: (2021)

Identification of PARP12 Inhibitors By Virtual Screening and Molecular Dynamics Simulations
Por: Tahani M. Almeleebia, et al.
Publicado em: (2022)

Structure of a Cyclic Peptide as an Inhibitor of <i>Mycobacterium tuberculosis</i> Transcription: NMR and Molecular Dynamics Simulations
Por: Filia Stephanie, et al.
Publicado em: (2024)

Molecular Dynamic Simulation and Docking of Cyclophilin A Mutants with its Potential Inhibitors
Por: Alireza Mohebbi, et al.
Publicado em: (2021)

Identification of novel AKT1 inhibitors from Sapria himalayana bioactive compounds using structure-based virtual screening and molecular dynamics simulations
Por: Laldinfeli Ralte, et al.
Publicado em: (2024)

Dynamics under Uncertainty: Modeling Simulation and Complexity
Publicado em: (2021)

Molecular docking study and molecular dynamics simulation of spice metabolites against main protease enzymes and NSP3 macrodomain SARS CoV-2
Por: Purwaniati Purwaniati, et al.
Publicado em: (2022)

Exploring Toxins for Hunting SARS-CoV-2 Main Protease Inhibitors: Molecular Docking, Molecular Dynamics, Pharmacokinetic Properties, and Reactome Study
Por: Mahmoud A. A. Ibrahim, et al.
Publicado em: (2022)

Molecular docking and dynamic simulations study for repurposing of multitarget coumarins against SARS-CoV-2 main protease, papain-like protease and RNA-dependent RNA polymerase
Por: Mai E. Shoman, et al.
Publicado em: (2022)

Structure-based screening of FDA-approved drugs identifies potential histone deacetylase 3 repurposed inhibitor: molecular docking and molecular dynamic simulation approaches
Por: Anas Shamsi, et al.
Publicado em: (2024)

Identification of Phytoconstituents as Potent Inhibitors of Casein Kinase-1 Alpha Using Virtual Screening and Molecular Dynamics Simulations
Por: Alaa Shafie, et al.
Publicado em: (2021)

Penilaian Hasil Molecular Docking Turunan Diketopiperazin Sebagai Inhibitor HIV-1 Protease
Por: Negara, Bayu Aji, et al.
Publicado em: (2014)

Penilaian Hasil Molecular Docking Turunan Diketopiperazin Sebagai Inhibitor Hiv-1 Protease
Por: Negara, Bayu Aji, et al.
Publicado em: (2014)

In silico screening and molecular dynamics simulations toward new human papillomavirus 16 type inhibitors
Por: Nima Razzaghi-Asl, et al.
Publicado em: (2022)

Supervised Molecular Dynamics (SuMD) Insights into the mechanism of action of SARS-CoV-2 main protease inhibitor PF-07321332
Por: Matteo Pavan, et al.
Publicado em: (2021)

Screening and identification of potential MERS-CoV papain-like protease (PLpro) inhibitors; Steady-state kinetic and Molecular dynamic studies
Por: Mohammed Ali Dahhas, et al.
Publicado em: (2023)

Monoamine transporters: Insights from molecular dynamics simulations
Por: Julie eGrouleff, et al.
Publicado em: (2015)

Discovery of potent heat shock protein 90 (Hsp90) inhibitors: structure-based virtual screening, molecular dynamics simulation, and biological evaluation
Por: Yonghua Xu, et al.
Publicado em: (2023)

Structure-guided drug repurposing identifies aristospan as a potential inhibitor of β-lactamase: insights from virtual screening and molecular dynamics simulations
Por: Moyad Shahwan, et al.
Publicado em: (2024)

Synthesis of Novel Bis-Coumarin Derivatives as Potential Acetylcholinesterase Inhibitors: An In Vitro, Molecular Docking, and Molecular Dynamics Simulations Study
Por: Zhila Zare-Akbari, et al.
Publicado em: (2022)

Repurposing of Oxicam Derivatives to Inhibit NDM-1: Molecular Docking and Molecular Dynamic Simulation Studies
Por: Pshtiwan Gharib Ali, et al.
Publicado em: (2024)

Docking studies and molecular dynamics simulation of Ipomoea batatas L. leaves compounds as lipoxygenase (LOX) inhibitor
Por: Yeni Yeni, et al.
Publicado em: (2020)

Design, Synthesis, Evaluation and Molecular Dynamics Simulation of Dengue Virus NS5-RdRp Inhibitors
Por: Keli Zong, et al.
Publicado em: (2023)

Qualitative and Quantitative Analysis of Anti-viral Compounds against SARS-CoV-2 Protease Enzyme by Molecular Dynamics Simulation and MM/PBSA Method
Por: Saghi Sepehri, et al.
Publicado em: (2021)

Potential of plant alkaloids as dengue ns3 protease inhibitors: Molecular docking and simulation approach
Por: Muhammad Tahir ul Qamar, et al.
Publicado em: (2014)

Potential of plant alkaloids as dengue NS3 protease inhibitors: Molecular docking and simulation approach
Por: Muhammad Tahir ul Qamar, et al.
Publicado em: (2014)

Functional and structural insights revealed by molecular dynamics simulations of an essential RNA editing ligase in Trypanosoma brucei.
Por: Rommie E Amaro, et al.
Publicado em: (2007)

Modification of -Adenosyl--Homocysteine as Inhibitor of Nonstructural Protein 5 Methyltransferase Dengue Virus Through Molecular Docking and Molecular Dynamics Simulation
Por: Usman Sumo Friend Tambunan, et al.
Publicado em: (2017)

An In Silico Study Based on QSAR and Molecular Docking and Molecular Dynamics Simulation for the Discovery of Novel Potent Inhibitor against AChE
Por: Meriem Khedraoui, et al.
Publicado em: (2024)

Identification of novel and potent dual-targeting HDAC1/SPOP inhibitors using structure-based virtual screening, molecular dynamics simulation and evaluation of in vitro and in vivo antitumor activity
Por: Yingxue Yang, et al.
Publicado em: (2023)